The Evolving Landscape of Immunotherapy in Locally Advanced Rectal Cancer Patients

SIMPLE SUMMARY: At the last 2022 annual ASCO meeting, impressive results of anti-PD1 activity in clinical stage 2 and 3 microsatellite instable rectal cancer patients have been published. Moreover, a growing number of studies assessed the synergism between neoadjuvant (chemo)radiotherapy and immunot...

Descripción completa

Detalles Bibliográficos
Autores principales: Germani, Marco Maria, Carullo, Martina, Boccaccino, Alessandra, Conca, Veronica, Masi, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496787/
https://www.ncbi.nlm.nih.gov/pubmed/36139613
http://dx.doi.org/10.3390/cancers14184453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496787/
https://www.ncbi.nlm.nih.gov/pubmed/36139613
http://dx.doi.org/10.3390/cancers14184453

Ejemplares similares